Psoriasis

The April issue covers atopic dermatitis, highlighting primary care’s role in early diagnosis, key updates from recent conferences, and more.

The findings highlight the potential of the interleukin-23 inhibitor to address a notoriously difficult-to-treat manifestation of psoriasis.

Findings showed that improved skin clearance and reduced anxiety and depression significantly influenced perceived patient benefit.